Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Neurology and Clinical Neuroscience|April 6, 2021
Infection control in the respiratory care of coronavirus disease-19 patients with neuromuscular diseasesTsuyoshi Matsumura, Toshio Saito, Masahide Mori, et al.
Genes|April 23, 2022
High Concentration or Combined Treatment of Antisense Oligonucleotides for Spinal Muscular Atrophy Perturbed <i>SMN2</i> Splicing in Patient FibroblastsYogik Onky Silvana Wijaya, Emma Tabe Eko Niba, Hisahide Nishio, et al.
Internal Medicine (Tokyo, Japan)|May 20, 2015
Safety of a Pandemic Influenza Vaccine and the Immune Response in Patients with Duchenne Muscular DystrophyTomoko Saito, Satoko Ohfuji, Tsuyoshi Matsumura, et al.
Shokuhin Eiseigaku Zasshi. Journal of the Food Hygienic Society of Japan|November 3, 2022
[Analysis of Ciguatoxins in the Spotted Knifejaw, Oplegnathus punctatus from the Waters of Japan]Takumi Tomikawa, Kyoko Kuniyoshi, Shiori Ito, et al.
Muscle & Nerve|December 8, 2022
Safety and immunogenicity of mRNA COVID-19 vaccine in inpatients with muscular dystrophyTomoko Saito, Toshio Saito, Hiroya Hashimoto, et al.
Muscle & Nerve|January 18, 2018
Validation of The Individualized Neuromuscular Quality of Life in Japanese patients with myotonic dystrophyHaruo Fujino, Toshio Saito, Masanori P Takahashi, et al.
Rinsho Shinkeigaku = Clinical Neurology|June 23, 2024
[Issues of transition support to adulthood and the practices of pediatric-adult healthcare transition in neurological diseases]Katsuhisa Ogata, Yoko Mochizuki, Satoko Kumada, et al.
Orphanet Journal of Rare Diseases|February 28, 2025
Analysis of SMN protein in umbilical cord blood and postnatal peripheral blood of neonates with SMA: a rationale for prompt treatment initiation to prevent SMA developmentNoriko Otsuki, Tamaki Kato, Mamoru Yokomura, et al.
Genes|October 23, 2021
Detection of Spinal Muscular Atrophy Patients Using Dried Saliva SpotsYogik Onky Silvana Wijaya, Hisahide Nishio, Emma Tabe Eko Niba, et al.
Neurology and Therapy|August 9, 2025
Safety of Risdiplam in Japanese Patients with Spinal Muscular Atrophy: A 12‑Month Interim Analysis of a Postmarketing Surveillance StudyKayoko Saito, Toshio Saito, Reiko Arakawa, et al.
Pageof 10